| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |